Die Vectura Aktie

TechMARK movers: Share buying in Antisoma

LONDON (SHARECAST) - Shares in cancer drug developer Antisoma have had little to cheer about in recent weeks. They plunged at the end of March following news that Novartis  had halted a Phase III trial for lung cancer treatment ASA404.

APG Algemene Pensioen Groep NV appears to believe that this is a buying opportunity and it has taken its stake to 3.17% of Antisoma.

The Vectura share price continues to decline. It is more than 5% lower on the week and down by more than one-quarter over the past month. In March, the pharma company agreed to take full control of the US development of asthma treatment VR315 back from Sandoz.

Many investors saw this as a negative and argued that taking on the development increased the risk for Vectura. There were positive reactions and broker FinnCap set a price target of 120p a share at the end of March. However, the negative view appears to be winning out.

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=3385608

starts Phase III trial

http://www.finanznachrichten.de/...tis-starts-phase-iii-trial-020.htm

http://translate.google.de/...mp;sl=en&tl=de&hl=&ie=UTF-8

vorgesehen.

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=3446448

http://translate.google.de/...mp;sl=en&tl=de&hl=&ie=UTF-8

As Loss Narrows

http://news.morningstar.com/newsnet/...OWJONESDJONLINE000044_univ.xml

VOTING RIGHTS AND CAPITAL

http://www.investegate.co.uk/Article.aspx?id=201009071009012688S

http://www.investegate.co.uk/Article.aspx?id=201010210700097474U

drugs

http://www.finanznachrichten.de/...novartis-respiratory-drugs-020.htm

http://news.morningstar.com/newsnet/...OWJONESDJONLINE000061_univ.xml

http://www.finanznachrichten.de/...aises-vectura-price-target-020.htm

http://www.investegate.co.uk/Article.aspx?id=201012310700107500Y

Vectura Group plc: Total Voting Rights

http://www.investegate.co.uk/Article.aspx?id=201012310700087511Y

http://www.investegate.co.uk/Article.aspx?id=201101190700076981Z

http://www.dofonline.co.uk/...mp;task=view&id=5082&Itemid=117

http://www.finanznachrichten.de/...vectura-group-price-target-020.htm

http://www.investegate.co.uk/Article.aspx?id=201102010700114191A

http://www.investegate.co.uk/Article.aspx?id=201102170700103796B

25.03.2011 08:27  
BRIEF-Vectura says positive Phase II data for respiratory drug

http://www.finanznachrichten.de/...-data-for-respiratory-drug-020.htm